Registered Yet?
Access your
CME tests, credits,
print certificates,
and more!
 Log In  
 Register  
 Join Our  Mailing List  
 
Mace Rothenberg, MD
Director, Phase I
    Drug Development Program,
Professor of Cancer Research,
    Vanderbilt-Ingram Cancer Center
Professor of Medicine,
    Division of Hematology/Oncology,
Vanderbilt University Medical Center
Nashville, TN
 
New Frontiers in Therapy for Difficult-to-Treat Cancers
  —Mace Rothenberg, MD, Executive Editor

- for reference only, not for CME credit

Part 1: New Agents and New Insights into Effective Treatment of GIST
  —Mace Rothenberg, MD & Emily Chan, MD, PhD
Download PDF
Part 2: New Agents and New Insights into Effective Treatment of mRCC
  —Robert Motzer, MD
Download PDF
New Options for Treatment of Colorectal Cancer
- for reference only, not for CME credit

Part 1: Adjuvant Therapy —
No Longer One Size Fits All
Download PDF
Part 2: Management and Prevention of Toxicities of Capecitabine- and Oxaliplatin-based Chemotherapies Download PDF
Part 3: Optimizing Outcomes with Combination Therapy Download PDF
Treatment of Colorectal Cancer - Mace Rothenberg, MD, Executive Editor
- for reference only, not for CME credit

Part 1: Dosing Considerations for Chemotherapeutic Agents in the Treatment of Colorectal Cancer  —Peter Enzinger, MD Download PDF
Part 2: Integration of Molecularly Targeted Agents into Chemotherapy
  —Mace Rothenberg, MD
Download PDF
Part 3: Treatment, Management, and Prevention of Toxicities Associated with Chemotherapy  —Howard Hochster, MD Download PDF
Advances in Treatment of Colorectal Cancer:
  —Mace Rothenberg, MD, Executive Editor

  —for reference only, not for CME credit

Recent Data on Anti-EGFR Agents
  —Mace Rothenberg, MD, & Emily Chan, MD, PhD
Download PDF
 
   
  © 2003-2008
  Health Focus, Inc.
  All rights reserved.
About Us | Contact Us | Privacy Policy